BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Market Cap

BridgeBio Pharma has a market cap or net worth of $4.57 billion as of April 19, 2024. Its market cap has increased by 98.68% in one year.

• Market Cap: 4.57B
• Enterprise Value: 5.89B
• 1-Year Change: 98.68%
• Ranking: #1264
• Category: Mid-Cap
• Stock Price: $24.74

Market Cap Chart

Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.17B to $4.57B, an increase of 44.09%. That is a compound annual growth rate of 7.88%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	4.39B	-0.12%
Apr 17, 2024	4.39B	-1.03%
Apr 16, 2024	4.44B	-2.06%
Apr 15, 2024	4.53B	-3.95%
Apr 12, 2024	4.72B	-5.39%
Apr 11, 2024	4.99B	3.77%
Apr 10, 2024	4.81B	-3.87%
Apr 9, 2024	5.00B	0.57%
Apr 8, 2024	4.97B	0.61%
Apr 5, 2024	4.94B	-0.18%
Apr 4, 2024	4.95B	-3.69%
Apr 3, 2024	5.14B	1.49%
Apr 2, 2024	5.06B	-3.94%
Apr 1, 2024	5.27B	-3.04%
Mar 28, 2024	5.44B	0.19%
Mar 27, 2024	5.43B	3.70%
Mar 26, 2024	5.23B	1.26%
Mar 25, 2024	5.17B	-0.64%
Mar 22, 2024	5.20B	2.07%
Mar 21, 2024	5.10B	1.22%
Mar 20, 2024	5.03B	0.70%
Mar 19, 2024	5.00B	2.23%
Mar 18, 2024	4.89B	0.91%
Mar 15, 2024	4.85B	0.77%
Mar 14, 2024	4.81B	-2.91%

View and export this data all the way back to 2019. Sign Up Today.

Related Stocks

Company	Market Cap
Halozyme Therapeutics	4.85B
Glaukos	4.83B
CRISPR Therapeutics AG	4.79B
Doximity	4.64B
Organon & Co.	4.59B
Krystal Biotech	4.53B
Madrigal Pharmaceuticals	4.51B
Lantheus Holdings	4.36B